Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis

Aliment Pharmacol Ther. 2003 Jan;17(1):155-64. doi: 10.1046/j.1365-2036.2003.01410.x.

Abstract

Objectives: To compare the safety and efficacy of pantoprazole with ranitidine for the maintenance of endoscopically documented healed (grade 0 or 1) erosive oesophagitis.

Methods: Patients (371) were randomly assigned to receive pantoprazole 10, 20 or 40 mg or ranitidine 150 mg. Endoscopies were performed after 1, 3, 6 and 12 months or when symptoms suggesting relapse (grade = 2) developed. Gastric biopsies were obtained at baseline and on at least one postbaseline visit. Symptom-free days and Gelusil use were assessed.

Results: Pantoprazole was significantly (P < 0.001) more effective in maintaining erosive oesophagitis healing. After 12 months, 33%, 40%, 68% and 82% of patients remained healed for the ranitidine and pantoprazole 10, 20 and 40 mg groups, respectively. Daytime and night-time heartburn were eliminated in > 90% of days for the pantoprazole 40 mg group. Gelusil use was significantly lower with pantoprazole 20 and 40 mg than with ranitidine (P < 0.02) during the first 9 months.

Conclusions: Twelve months of maintenance therapy with pantoprazole (10-40 mg once daily) was superior to ranitidine (150 mg twice daily) in maintaining erosive oesophagitis healing. Pantoprazole 40 mg provided the most consistent efficacy and was well tolerated.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Aged
  • Aluminum Hydroxide / administration & dosage
  • Anti-Ulcer Agents / administration & dosage*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use*
  • Double-Blind Method
  • Drug Combinations
  • Esophagitis / drug therapy*
  • Female
  • Humans
  • Magnesium Hydroxide / administration & dosage
  • Male
  • Middle Aged
  • Omeprazole / analogs & derivatives
  • Pantoprazole
  • Ranitidine / administration & dosage*
  • Recurrence
  • Silicic Acid / administration & dosage
  • Sulfoxides / adverse effects
  • Sulfoxides / therapeutic use*
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Drug Combinations
  • Sulfoxides
  • Silicic Acid
  • Aluminum Hydroxide
  • Gelusil
  • Ranitidine
  • Pantoprazole
  • Omeprazole
  • Magnesium Hydroxide